相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Heart rate variability is reduced in underweight and overweight healthy adult women
Antonio Ivano Triggiani et al.
CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING (2017)
Nandrolone decanoate interferes with testosterone biosynthesis altering blood-testis barrier components
Rosario Barone et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
Quality of life in overweight (obese) and normal-weight women with polycystic ovary syndrome
Annalisa Panico et al.
PATIENT PREFERENCE AND ADHERENCE (2017)
Osteopontin: Relation between Adipose Tissue and Bone Homeostasis
Carolina De Fusco et al.
STEM CELLS INTERNATIONAL (2017)
Role of Autonomic Nervous System and Orexinergic System on Adipose Tissue
Giovanni Messina et al.
FRONTIERS IN PHYSIOLOGY (2017)
Mutational Signatures in Breast Cancer: The Problem at the DNA Level
Serena Nik-Zainal et al.
CLINICAL CANCER RESEARCH (2017)
Metastatic Breast Cancer with BRCA Mutation Discovered By Next-Generation Sequencing Responding to Olaparib
Wajeeha Rizvi et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2017)
Germline Mutations in Triple-Negative Breast Cancer
Eric Hahnen et al.
BREAST CARE (2017)
Effects of Nandrolone Stimulation on Testosterone Biosynthesis in Leydig Cells
Cristoforo Pomara et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2016)
Heart-Rate Changes After an Ultraendurance Swim From Italy to Albania: A Case Report
Anna Valenzano et al.
INTERNATIONAL JOURNAL OF SPORTS PHYSIOLOGY AND PERFORMANCE (2016)
Short-Term Diet and Moderate Exercise in Young Overweight Men Modulate Cardiocyte and Hepatocarcinoma Survival by OxidativeL Stress
Marcellino Monda et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2014)
Sera of overweight people promote in vitro adipocyte differentiation of bone marrow stromal cells
Giovanni Di Bernardo et al.
STEM CELL RESEARCH & THERAPY (2014)
Nuclear Translocation of Heme Oxygenase-1 Confers Resistance to Imatinib in Chronic Myeloid Leukemia Cells
Daniele Tibullo et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Efficacy of adipose tissue-mesenchymal stem cell transplantation in rats with acetaminophen liver injury
Federico Salomone et al.
STEM CELL RESEARCH (2013)
Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice
Giovanni Li Volti et al.
CARDIOVASCULAR DIABETOLOGY (2011)
Effect of Endocrine Therapies on Bone in Breast Cancer Patients
R. J. Santen
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study
Karine Briot et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Prevention of Aromatase Inhibitor-Induced Bone Loss Using Risedronate: The SABRE Trial
Catherine Van Poznak et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
How Do Bisphosphonates Inhibit Bone Metastasis In Vivo?
Pierrick G. Fournier et al.
NEOPLASIA (2010)
Bisphosphonate-Associated Osteonecrosis of the Jaw Patient Care Considerations: Overview for the Orthopaedic Nursing Healthcare Professional
Harold V. Cohen
ORTHOPAEDIC NURSING (2010)
Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial
Christos Markopoulos et al.
BREAST CANCER RESEARCH (2010)
Osteonecrosis of the Jaw and the Role of Bisphosphonates: A Critical Review
Stuart L. Silverman et al.
AMERICAN JOURNAL OF MEDICINE (2009)
Aromatase Inhibitor-Related Musculoskeletal Symptoms: Is Preventing Osteoporosis the Key to Eliminating These Symptoms?
Alaa A. Muslimani et al.
CLINICAL BREAST CANCER (2009)
Bisphosphonate-associated adverse events
Peter D. Papapetrou
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2009)
Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Risedronate for the Prevention of Bone Loss in Premenopausal Women Undergoing Chemotherapy for Primary Breast Cancer
Stephanie L. Hines et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Safety profiles of aromatase inhibitors and selective estrogen-receptor modulators in the treatment of early breast cancer
Yutaka Yamamoto et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2008)
Risedronate prevents bone loss in breast cancer survivors: A 2-year, randomized, double-blind, placebo-controlled clinical trial
Susan L. Greenspan et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial
Norman Williams
LANCET ONCOLOGY (2008)
Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw:: Is there a diverse relationship of amino- and non-aminobisphosphonates?
Ingo J. Diel et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Prevention of bone loss in survivors of breast cancer: A randomized, double-blind, placebo-controlled clinical trial
Susan L. Greenspan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial
A. Buzdar et al.
LANCET ONCOLOGY (2006)
Long-term effects of aromatase inhibitors on bone
R Eastell et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
Bisphosphonates for breast cancer
N Pavlakis et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2005)
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer
A Howell et al.
LANCET (2005)
Preventing osteoporotic fractures with antiresorptive therapy: implications of microarchitectural changes
S Boonen et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Drug therapy: Aromatase inhibitors in breast cancer
IE Smith et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Definition of a population-specific DXA reference standard in Italian women: The Densitometric Italian Normative Study (DINS)
M Pedrazzoni et al.
OSTEOPOROSIS INTERNATIONAL (2003)
Risedronate -: A clinical review
C Crandall
ARCHIVES OF INTERNAL MEDICINE (2001)